Audience: Pharmacists, other healthcare professionals
Healthcare professionals advised of a critical shortage of Cytovene-IV, indicated for the treatment or prevention of cytomegalovirus (CMV) disease. This shortage in supply is expected to last through the second quarter of 2002. Roche urges physicians to explore alternative treatment therapies or management strategies for their patients. This temporary situation affects only the IV formulation of Cytovene.
[March 13, 2002 - Letter - Roche]
[Feb 13, 2002 - Letter - Roche]